The Hidden Cost of Venture Capital Most Long-Term Investors Overlook
Every few years, a blockbuster IPO — SpaceX, OpenAI, the next rocketship — reignites the dream that venture capital is the secret sauce separating good investors from great ones. The math rarely works out that way. And for patient investors building wealth over decades, the VC trade-off deserves far more scrutiny than it typically gets.
Here is the number that should give every aspiring venture investor pause: the median VC fund historically delivers a net IRR of roughly 8% to 12%. That is nearly identical to the S&P 500’s long-run average of around 10% — and the S&P delivers that return with full daily liquidity, no capital calls, and no annual K-1 tax headaches. Meanwhile, the Nasdaq has compounded roughly 6.5 times over the past decade alone, available to anyone with a brokerage account and zero lock-up period. Top-quartile VC funds do exist — generating 20% to 30%+ IRRs — but access to those elite managers is almost entirely invite-only. Sequoia, Benchmark, Founders Fund, and Andreessen Horowitz don’t accept unsolicited capital from everyday investors. What is actually available to most people sits squarely in that median band, where the illiquidity premium is thin at best.
The timeline math makes it worse. A traditional venture fund launched in 2026 typically involves three to five years of capital calls through 2030, a decade of K-1 filings, and a projected return of capital — if all goes well — somewhere between years eight and eleven. That means money committed today might not fully return until 2034 to 2037. For a 40-year-old investor, that is manageable. For a 55-year-old, it lands precisely during the years they may most want financial flexibility: funding a child’s education, managing an aging parent’s care, or simply enjoying the compounding they spent decades building. Liquidity is not a fixed utility — it becomes more valuable, not less, as a portfolio matures. A dollar locked in a VC fund at 60 is worth fundamentally less than a dollar in a liquid index fund, because optionality has real economic value.
So what does this mean for long-term investors? The lesson is not that venture capital is bad. It is that venture capital is frequently mispriced in investors’ minds — given a premium valuation based on headline stories rather than median outcomes. For the vast majority of patient capital allocators, a broadly diversified equity portfolio in low-cost index funds offers comparable returns, superior liquidity, and none of the administrative burden. If you do pursue private alternatives, the bar should be high: access to genuinely top-tier managers, an allocation sized well below 20% of investable assets, and a time horizon you can honestly afford to lock up. The greatest compounding machines in history — quality businesses with durable competitive advantages — remain openly listed on public exchanges every single trading day. That accessibility is an underappreciated edge, not a consolation prize.
